Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AMBBY and 80,000+ other tickers.
See exactly how AMBBY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AMBBY and 80,000+ other tickers.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single…
Ambu A/S (AMBBY) Q3 2026 Earnings Call Transcript
Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) shares saw unusually-high trading volume on Friday. Approximately 500 shares traded hands during trading, a decline of 29% from the previous session's volume of 708 shares.The stock last traded at $11.00 and had previously closed at $10.20. Ambu A/S Stock Performance The stock has a
Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s share price was up 3.4% during mid-day trading on Tuesday. The company traded as high as $13.78 and last traded at $13.78. Approximately 500 shares changed hands during trading, an increase of 495% from the average daily volume of 84 shares. The stock had previously